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Development of a Label-free Raman Imaging Technique for 
Differentiation of Malaria Parasite Infected from Non-Infected 
Tissue   
Laura Frame,a James Brewer,b Rebecca Lee,b Karen Faulds,a and Duncan Graham*a 
During malarial infection, the host uses the spleen to clear the malaria parasites, however, the parasites have evolved the 
ability to bind to endothelial receptors in blood vessels of tissues to avoid removal, known as sequestration, and this is 
largely responsible for the symptoms and severity of infection. So a technique which could non-invasively diagnose tissue 
burden could be utilised as an aid for localised malaria diagnosis within tissue. Raman spectroscopy is a label-free imaging 
technique and can ƉƌŽǀŝĚĞƵŶŝƋƵĞĂŶĚĐŚĞŵŝĐĂůůǇƐƉĞĐŝĨŝĐZĂŵĂŶ ‘ĨŝŶŐĞƌƉƌŝŶƚ ?ƐƉĞĐƚƌƵŵŽĨďŝŽůŽŐŝĐĂůƐĂŵƉůĞƐƐƵĐŚĂƐƚŝƐƐƵĞ ?
Within this study, Raman imaging was used to observe the changes to the molecular composition of mice spleen tissue 
under malarial infection, compared with non-infected samples. From analysis of the Raman imaging data, both tissue types 
showed very similar spectral profiles, which highlighted that their biochemical compositions were closely linked. Principal 
component analysis showed very clear separation of the two sample groups, with an associated increase in concentration 
of heme-based Raman vibrations within the infected dataset. This was indicative of the presence of hemozoin, the malaria 
pigment, being detected within the infected spleen. Separation also showed that as the hemozoin content within the tissue 
increased, there was a corresponding change to hemoglobin and some lipid/nucleic acid vibrations. These results 
demonstrate that Raman spectroscopy can be used to easily discriminate the subtle changes in tissue burden upon malarial 
infection.  
Introduction 
Malaria is a mosquito-borne infectious disease, caused by the 
Plasmodium parasite1 and is a leading cause of morbidity and 
mortality in the developing world.2 Five species are known to 
cause malaria infection in humans, with Plasmodium falciparum 
(P.falciparum) being responsible for a large number of cases in 
Africa.1,3 
During the erythrocytic infection phase, the parasite catabolises 
up to 80 %4 ŽĨ ƚŚĞ ŚŽƐƚƐ ? ŚĞŵŽŐůŽďŝŶ ? dŚŝƐ ŽĐĐƵƌƐ ǁŝƚŚŝŶ ƚŚĞ 
digestive vacuole of the parasite5 and produces free heme as a 
by-product (ferrous [FeII] protoporphyrin IX)6, which is toxic to 
the parasite.5  To detoxify this, the parasite oxidises it to an 
insoluble, crystalline material known as hemozoin or the 
malaria pigment.5,7 At the end of the erythrocytic cycle, red 
blood cells (RBCs) rupture, releasing hemozoin and parasites 
into the bloodstream, with the parasites going on to infect 
further RBCs and continue the cycle of infection. While 
hemozoin, under physiological conditions, is not degraded and 
circulates in the bloodstream until it is digested by macrophages 
present within specific organs.7 The spleen is the primary organ 
involved in the development of an immune response8 during 
the erythrocytic stage of infection along with the elimination of 
parasitised RBCs and hemozoin.9,10 However, P.falciparum 
proteins on the surface of infected erythrocytes give these cells 
the ability to bind to endothelial receptors in blood vessels of 
tissue, leading to sequestration2,11 of these infected cells and 
hence reduced clearance from the bloodstream.2 Sequestration 
of parasites into tissue is largely responsible for the severity and 
symptoms of infection12,13, therefore, a technique which could 
non-invasively detect tissue burden would be a great step 
forward.  
Raman spectroscopy has been extensively used for the 
identification of malaria infection most commonly via the 
detection of hemozoin. It has been widely reported by groups 
including Frosch et al.4 and Wood et al.14 that the choice of 
Raman excitation wavelength is key to gaining selective 
enhancement of hemoglobin and hemozoin bands over other 
non-resonant cellular components. Wood et al.15 reported that 
by exploiting the resonance Raman characteristics of hemozoin, 
coupled with partial dark field microscopy, there was potential 
to detect low-ƉŝŐŵĞŶƚĞĚƉŚĂƐĞƐŽĨƚŚĞŵĂůĂƌŝĂƉĂƌĂƐŝƚĞ ?Ɛ ůŝĨĞ-
cycle within infected erythrocytes. More recently, Hobro et al.16 
applied resonance Raman imaging to study the progression of 
malaria infection via blood and plasma samples. They showed 
that within infected blood samples, changes associated with a 
loss of hemoglobin and an increase in hemozoin could be 
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detected after four days of infection. However, hemozoin 
detection limits were shown to be reduced to only one day, 
following Plasmodium infection, when plasma samples were 
analysed due to a reduced heme background. Resonance 
Raman spectroscopy has also been used within a multimodal 
imaging approach to study the disease mechanisms of murine 
cerebral malaria.17 This work by Hackett et. al.17 showed strong 
evidence that during cerebral malaria infection iron-mediated 
protein oxidation occurs within the tissue.  
These studies highlight how valuable Raman spectroscopic 
techniques are for the study of biological matrices within 
malarial infection. Because Raman spectroscopy is a powerful, 
label-free technique, it can provide a unique and chemically 
ƐƉĞĐŝĨŝĐZĂŵĂŶ ‘ĨŝŶŐĞƌƉƌŝŶƚ ?ƐƉĞĐƚƌƵŵŽĨďŝŽůŽŐŝĐĂůƐĂŵƉůĞƐ ?18 ?20 
It has a number of advantages for studying these types of 
materials including requiring minimal to no sample 
preparation18; being a non-destructive technique21; and 
allowing specific chemical information to be gained without the 
use of stains.22 During the pathogenesis of disease, biological 
alterations occur, which lead to changes in the biochemical 
composition of affected tissues. These changes in structure, 
concentration and composition of biomolecules can be 
reflected in the Raman spectra of tissue samples. Indeed, 
Raman spectroscopy has been used to study the subtle 
molecular changes in tissue samples associated with other 
diseases including, lung23 cancer; breast20,24 cancer; and 
diabetes.18 
In this work, we used Raman spectroscopic imaging to study the 
changes in the biochemical composition of mouse spleen tissue 
sections following infection with the rodent parasite, 
Plasmodium berghei (P. berghei). We compared the Raman 
spectra of infected with non-infected samples to detect changes 
in the Raman spectral signature associated with infection. The 
multivariate chemometric analysis technique, principal 
component analysis (PCA) was applied to decompose the 
spectral data into components and attempt to identify subtle 
changes to biological components within tissue sections which 
could differentiate infected tissue burden from non-infected 
samples. 
Materials and methods 
Infections and tissue preparation  
Procedures on mice were approved following local ethical 
review by the University of Glasgow Animal Procedures and 
Ethics Committee and were performed in strict accordance with 
the UK Home Office Animals (Scientific Procedures) Act 1986 
(Project Licence No. P2F28B003). Two female, BALB/c mice 
(Harlan, Bicester, UK; 6-8 weeks old) were infected with 
asynchronous P. berghei ANKA, and euthanised when 
peripheral blood parasitemia reached 5 %. At this level, 
although high, the infection is asymptomatic in BALB/c mice. 
Spleens were removed from these and from two uninfected 
control mice and embedded in tissue freezing medium (Tissue-
Tek O.C.T.).25 This freezing medium was used to preserve the 
tissue structure. Frozen tissue blocks were then positioned in a 
cryostat chamber at -22°C, cut into sections with a thickness of 
10 µm and placed on poly-L-lysine glass slides with Tissue-Tek 
O.C.T. Ten tissue sections were taken from the infected spleens, 
along with a further ten from the uninfected spleens. Tissue 
sections on glass slides were stored at -20°C prior to analysis. 
Spleen tissue was chosen as it is a key tissue for the 
sequestration of the parasite. 
 
Reference spectra  
Synthetic hemozoin was prepared using methods reported by 
Egan et. al.26,27 (full synthetic method is given in ESI S1) and a 
2.5 mg/mL solution prepared with PBS (10 mM, pH 7.2). 
Hemoglobin was purchased from Sigma-Aldrich and a 10 mg/mL 
solution prepared with PBS. 100 µL of each solution were 
spotted on glass coverslips and allowed to dry overnight before 
analysis. 
 
Raman spectroscopy  
Tissue sections were left to thaw at room temperature, washed 
once with PBS (10mM, pH 7.2) and finally rinsed in d.H2O. 
Raman mapping was performed using a Renishaw inVia Raman 
spectrometer equipped with 532 nm laser excitation (5 % laser 
power, 1 mW) and an 1800 l/mm grating.  Raman images of 
uninfected and infected malaria tissue were recorded using a 
x50 objective (NA = 0.75) with an integration time of 3 s per 
spectrum, a step size of 1 µm, and in the spectral range of 680 
 ? 2330 cm-1. 
Hemoglobin and hemozoin reference spectra were collected 
using a x20 objective, 30 s acquisition time per spectra and a 
532 nm laser excitation (1 % laser power, 0.1 mW). 
 
Data pre-processing  
In all datasets, a cosmic ray removal algorithm was first applied 
within WiRE 4.2 software. This algorithm sets values for width 
and height of features to detect potential cosmic rays, which are 
then accepted or rejected by the programmer. Noise filtering 
was then applied within the same software, to reduce the level 
of random noise within the data whilst maintaining the 
important Raman spectral features. This pre-processing method 
applies a form of PCA to the dataset, which subsequently 
provides scores and loadings for each principal component (PC) 
to determine whether components primarily relate to real 
Raman signals or noise. The optimum number of PCs, which 
describe all the real Raman signal with minimal noise 
interference, can then be selected for each Raman map. Raman 
spectra were baseline corrected using an asymmetric least 
square smoothing algorithm28 operating in Matlab R2013a 
software (The MathWorks, Natick, MA, USA). Finally, all 
datasets were truncated so only the fingerprint region of 
interest was studied (700  ? 1700 cm-1).  
The reference spectra shown are the average of five spectra, 
that were baselined using the same asymmetric least square 
smoothing algorithm as above. 
 
Empirical analysis  
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In this study, the empirical analysis focused on the ratio of the 
Raman peak intensity at ~745 cm-1 (v15 hemoglobin)29,30, to the 
peak intensity at ~1307 cm-1 (v21 hemoglobin & lipids)18,29 for 
ďŽƚŚ ƚŝƐƐƵĞ ƚǇƉĞƐ ? Ŷ ƵŶƉĂŝƌĞĚ ƐƚƵĚĞŶƚ ?Ɛ ƚ-test was used to 
assess whether the difference in the Raman intensity ratio 
(I745/I1307) between non-infected and infected tissues was 
statistically significant.18,19 To manage the data for analysis, all 
infected Raman maps were combined to give one large data 
matrix containing thousands of Raman spectra, the same 
process was carried out with the uninfected data. These were 
then averaged to leave 43 final infected Raman spectra and 43 
control spectra (n = 43). These data were subsequently used for 
empirical and multivariate analysis.  The intensity ratios for all 
samples were plotted to observe sample distribution, along 
with the average intensity ratio plot for both the control and 
infected tissue. This analysis was performed on the same data 
set, used for the PCA model. 
 
Multivariate analysis  
PCA was applied to highlight any spectral separation between 
the control and infected data sets using Matlab software 
version R2013a (The MathWorks, Natick, MA, USA). Multiple 
maps for both tissue types were combined and averaged to give 
43 final spectra for both the control and infected tissue data 
sets. The dataset was then normalised and mean centred prior 
to PCA being applied. Principal component one (PC1) was then 
plotted against principal component two (PC2). The loadings 
plots were also plotted to determine correlation. All analysis 
within Matlab software was performed using custom scripts. 
Results and Discussion  
Average spectra of non-infected and malaria parasite infected 
tissue 
In this study two approaches were used to analyse the large 
spectral data sets. Firstly, spectral features were studied and 
changes in relative peak intensity investigated using intensity 
ratio maps and empirical analysis. The second approach used 
PCA to determine the primary spectral features resulting in 
correlations or anti-correlation between the infected and non-
infected tissue, by creating principal components to explain the 
data set variance in an unsupervised manner. 
Figure 1: Analysis of Raman peak intensity for control and P. berghei-infected tissue sections. (A) Averaged, normalised spectra from a mapped area of control and infected 
tissue. Spectra were then normalised against the peak at 1585 cm-1. Tentative peak assignments are also given in Table 1. (B) Subtracted Raman spectrum. The average, 
normalised control spectrum was subtracted from the average, normalised infected spectrum, both shown in (A), to highlight any potential biological components that 
were being altered within the malaria infected tissue. (C) Image shows white light images of both tissue sections, with the grey box indicating the area that was mapped, 
along with peak intensity ratio maps for selected Raman peaks. Intensity ratio maps were created using the peak intensities for: 745 cm-1, 1130 cm-1, 1170cm-1, and 1307 
cm-1 (I745 / I1307; I1130 / I1307; I1170 / I1307). These ratio maps visually show relative changes in the intensity of these Raman peaks within the area of P. berghei-infected tissue 
that was mapped compared to the uninfected area. These maps suggest an increase or alteration to some key biological components within the infected tissue including, 
multiple hemoglobin vibrations29, lipids31, and proteins30.
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Figure 1A shows the averaged, normalised Raman spectra 
obtained from a non-infected (control) tissue map and a P. 
berghei infected mouse spleen tissue map. Both tissue types 
showed a very similar spectral profile, highlighting that the 
biochemical compositions were closely linked. Tentative peak 
assignments of the Raman bands are listed in Table 1. However, 
differences in the relative Raman peak intensities for infected 
vs. control tissue were observed. These were highlighted 
through subtraction of the average, normalised control spectra 
from the infected (Figure 1B). This emphasised some peaks that 
appeared to increase (~745, 1130, 1170 and 1225 cm-1) and 
decrease (~1087 and 1439 cm-1) in Raman signal intensity within 
the P. berghei infected tissue compared with the control. This 
change in relative peak intensity suggests an alteration in the 
biological composition of the spleen at this level of infection, 
characterised by changes in level and/or composition of the 
biological species assigned to these Raman signals. 
Intensity ratio maps (Figure 1C) were created to visually show 
these relative peak changes, using the 1307 cm-1 peak as a 
constant background. These heat intensity maps showed a clear 
overall increase in the peak intensity ratios within the infected 
mapped areas compared to the control samples. This suggests 
alterations to biological components including hemoglobin29,32 
(~745, 1130 and 1170 cm-1), lipids30 (~1130 cm-1) and other 
proteins30 (~1170 cm-1) at this level of P. berghei infection. Ratio 
maps were also created for different samples to show this 
overall increase was common throughout the infected tissue 
(ESI Figure S2). Within these maps, for both uninfected and 
infected samples, particularly intense regions are present 
(Figure 1C and ESI Figure S2). This can be explained through 
enhanced Raman intensity from resonance contributions of the 
biological components within these areas of tissue.  These ratio 
maps visually show relative changes in biological peaks in a 
simple manner and can be used alongside empirical analysis and 
PCA to aid in classification of tissue types from Raman 
spectroscopy data. 
Table 1. Tentative peak assignments for the main peaks observed in the spectral profile 
for both non-infected and P. berghei infected spleen samples. 
Raman Shift (cm-1) Assignmenta 
745 v15 Hb [v(pyr breathing)] 
998 Proteins (Phe), v45 Hb [v(CC)asym] 
1087 DNA / Nucleic acids [vs (PO2-), v (CC)], Hb 
1130 Lipids, v5 Hb [Ɂ(=CH2)4] 
1170 Proteins (Tyr), v30 Hb [v(pyr half -ring)asym] 
1225 Proteins (Amide III), v13/v42 Hb [Ɂ(CH)] 
1307 Lipids, v21 Hb [Ɂ(CH)] 
1338 Nucleic acid modes, v41 Hb [v(pyr half-ring)sym] 
1370 v4 Hb [v(pyr half-ring)sym] 
1396 CH2 deformation, v20 Hb [v(pyr quarter-ring)] 
1439 Lipids [Ɂ(CH2)] 
1561 v11 Hb [v(CC)] 
1585 v37 Hb [v(CC)asym] 
1618 v19 Hb [v(CC)asym] 
1636 Proteins (Amide I), v10 Hb [v(CC)asym] 
a Abbreviations: v  ? ƐƚƌĞƚĐŚ ǀŝďƌĂƚŝŽŶ ? ɷ  ?in-plane bending vibration; sym  ? 
symmetric; asym  ? asymmetric; Hb  ? hemoglobin; Phe  ? phenylalanine; Tyr  ? 
tyrosine. Assignments from ref. 16, 18,29-31 
Empirical analysis of Raman spectra 
Diagnostic algorithms based on peak intensity ratios have been 
widely employed in the literature for tissue classification using 
Raman spectroscopy.18,19,23 These have been shown to 
successfully correlate variations in tissue spectra with tissue 
pathology19 in a simple manner. 
An empirical analysis based on the peak intensity ratio of two 
Raman bands was used for tissue classification within this study. 
Figure 2A shows the scatter plot of the ratio of Raman peak 
intensity at 745 cm-1 to 1307 cm-1 (I745/I1307) for the 43 averaged 
P. berghei infected samples and 43 uninfected samples. A clear 
separation was observed in the scatter plot for the two data 
sets, with replicate data within each tissue type being grouped 
closely together, indicating little intra-sample variation in the 
intensity ratios. The mean ratio values (mean ± std. dev.) for 
both control (0.903 ± 0.015) and infected (1.119 ± 0.021) data 
sets were also plotted (Figure 2B). It was shown that the 
differences between the mean ratios for each tissue type were 
statistically relevant (unpairĞĚ ƐƚƵĚĞŶƚ ?Ɛ ƚ-test, p < 0.0001). 
Infected tissue showed a higher ratio value compared with 
control, this could be explained by the increase in heme-based 
Raman vibrations (~745 cm-1 assigned to v15 Hb29) due to the 
presence of hemozoin within the infected samples. 
From these results, this intensity ratio is a potential simple and 
reliable marker to indicate the presence of infection. It has also 
been shown that other peak ratios can also be used to classify 
the two tissue types with good results (ESI Figure S3). However, 
this method does not consider the entire Raman spectrum. To 
help improve tissue analysis and classification, PCA was 
employed to highlight the most diagnostically significant Raman 
peaks. 
Figure 2: Empirical analysis results. (A) Scatter plot of peak intensity ratios (I745/ I1307) 
for 43 average Raman spectra from all the control and malaria infected mice spleen 
tissue that were mapped. A clear separation of the two data sets was observed, 
with little intra-sample variability.  (B) Average intensity ratio plots for the control 
(0.903 ± 0.015) and infected (1.119 ± 0.021) data sets. This difference in mean ratios 
was shown to be statistically relevant (unpaired StuĚĞŶƚ ?Ɛƚ-test, p < 0.0001).
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Principal component analysis  
PCA was used to analyse this data set to better distinguish the 
spectral differences between the non-infected and infected 
spleen tissue. Figure 3 shows the scores plot for PC1 (97.6 %  
variance) and PC2 (1.45 % variance), along with the 
corresponding loadings vectors. As can be seen from the scores 
plot (Figure 3A) PC1 was primarily responsible for the 
separation of the two tissue types. The loadings plot (Figure 3B) 
for PC1 indicated that the peaks in the negative half of the plot 
were spectrally important for describing the separation of the 
infected tissue (~750, 1130, 1170, 1225, 1370, 1529, 1588 and 
1628 cm-1), with the latter few being more indicative of 
hemozoin than hemoglobin. The negative peaks at ~1529, 1588 
and 1628 cm-1 matched closely with that of the hemozoin 
reference spectra in Figure 4 (core structures of hemoglobin 
and hemozoin shown in ESI S4 to highlight structural 
similarities) and therefore suggested detection of the insoluble  
pigment by Raman. The negative ~1370 cm-1 peak was present 
in both reference spectra; however, it was much more 
prominent within hemozoin and so suggested that hemozoin 
was contributing to this peaks appearance within the PC1 
loadings plot. It is well known that hemozoin accumulates 
within the spleen8,9 (presence of hemozoin within the infected 
spleen can be seen in stained tissue images, ESI S5), therefore it 
follows that there will be an associated increase in 
concentration of heme-based Raman vibrations. This is clearly 
shown in this PCA model as many of these peaks separating the 
infected tissue from the uninfected samples can be assigned to 
heme-vibrations, including hemozoin. Although other proteins 
and lipids will be present and exhibit Raman bands in similar 
positions to those of hemoglobin (~1130, 1170, 1225 & 1396 
cm-1), resonance effects would mean hemoglobin will tend to 
dominate the spectra (excitation in the regions of Q-absorption 
bands)29,32,33, with the other proteins and lipids having only 
small contributions to the observed spectra.  
Within the positive peaks in the PC1 loadings plot, the relatively 
broad ~1087 cm-1 peak is likely to have a significant contribution 
from hemoglobin (Figure 4), however, its broadness suggested 
contributions from other components. Raman bands within this 
region can also be assigned to C-C and O-P-O vibrations of 
nucleic acids.18,30 The other prominent positive peak at ~1439 
cm-1 can mainly be assigned to Raman vibrations from lipids18,31, 
although it may also have slight hemoglobin contributions 
(~1432 cm-1 peak in reference spectra). Analysis of the PC1 
loadings plot indicated that at this level of P. berghei malaria 
infection Raman spectroscopy can clearly detect hemozoin 
accumulation within the spleen, with the positive peaks (~1087 
Figure 3. PCA plot for control and malaria infected samples from mouse spleen tissue sections. (A) Scores plot showing very clear separation of the control (green) and 
infected (blue) data sets. Separation is occurring mainly along PC1, with little separation along PC2. (B) Loadings plots for PC1 and PC2, with the main peaks in both 
indicated. The peaks in the negative half of PC1 are responsible for the separation of the infected samples along PC1 away from the control samples. 
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and 1439 cm-1) indicating that as the amount of hemozoin 
increases within the spleen there is a corresponding change to 
hemoglobin and some lipids/nucleic acid vibrations.  
PC2 describes little separation between the control and 
infected samples. From the PC2 loadings plot (Figure 3B) the 
positive peaks (~1550, 1568, 1601 cm-1) originate mainly from 
hemoglobin vibrations, whereas the negative peaks have 
contributions from hemoglobin as well as from other 
proteins18,30 (~1170, 1225 and 1636 cm-1) and lipids31 (~1127 
cm-1). This PCA analysis indicates that Raman imaging can easily 
distinguish between P. berghei infected spleen tissue from 
uninfected samples, through identification of hemozoin 
accumulation and alterations to other key biological 
components. 
Conclusions 
In conclusion, a combination of Raman imaging with 
multivariate analysis resulted in very clear discrimination of P. 
berghei infected tissue from non-infected samples. Separation 
highlighted an overall increase in heme-based Raman vibrations 
within the infected samples, which correlates with the 
accumulation of hemozoin within the spleen contributing to 
this. Hemozoin detection was clear with the identification of key 
peaks occurring ~1370, 1529, 1588, and 1628 cm-1 which 
matched closely with the reference spectra. Chemometric 
analysis also showed that at the level of P. berghei infection 
reported here, changes to hemoglobin and some other 
lipid/nucleic acid vibrations corresponded with an increase in 
hemozoin content within the spleen. Other proteins (tyrosine 
~1130 cm-1, and Amide III ~1225 cm-1) and lipids (~1130 cm-1) 
were also contributing to the separation of infected tissue from 
control. However, due to the resonance effects of heme-based 
compounds the separation contribution from these biological 
components would have been small.  
The use of peak ratio maps and empirical analysis also 
highlighted changes to the biological components as you move 
towards an infected tissue state. These two simple data analysis 
methods could be used as tools in combination with the PCA to 
help improve efficiency of Raman tissue analysis and 
classification. 
As the Raman imaging technique used in this study had a short 
penetration depth, it would not be suitable for in vivo 
diagnostics. However, with the development of spatially offset 
Raman spectroscopy, which allows accurate analysis through 
millimetres of material when obscuring barriers such as skin are 
present34,35, this may allow for biochemical information from 
tissue to be detected in vivo in the near future. Overall, this 
approach demonstrates the potential use of Raman 
spectroscopy to provide detailed chemical information from 
both malaria parasite infected and control tissue and when 
coupled with PCA, discrimination due to infection burden is 
achievable between the two sample groups. 
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